ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹23 Cr | ₹20 Cr | ₹26 Cr | ₹32 Cr | ₹34 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹34 Cr |
How is Deferred Tax Assets / Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | 16.96 | |
| Mar2024 | ₹20 Cr | -22.57 | |
| Mar2023 | ₹26 Cr | -18.68 | |
| Mar2022 | ₹32 Cr | -6.33 | |
| Mar2021 | ₹34 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,631.7 Cr | -2% | 4.2% | -13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,566.0 Cr | 1.2% | 5.3% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,594.0 Cr | -0.7% | -2.1% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,826.0 Cr | -3.2% | 4.1% | 20.2% | Stock Analytics | |
| CIPLA | ₹123,504.0 Cr | -0.2% | -6.7% | 1.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,132.0 Cr | 0.2% | -2.7% | 2% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -2% |
4.2% |
-13.7% |
| SENSEX | 1.4% |
2% |
10.2% |
You may also like the below Video Courses